Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT

v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Mar. 31, 2021 $ (112,245) $ 570 $ 626,664 $ (738,623) $ (856)
Beginning balance (in shares) at Mar. 31, 2021   56,915,000      
Increase (Decrease) in Stockholders' Equity          
Net loss (4,153)     (4,153)  
Foreign currency translation adjustments, net 267       267
Shares issued under employee stock purchase plan 0 $ 3 (3)    
Shares issued under employee stock purchase plan (in shares)   365,000      
Stock-based compensation 3,201   3,201    
Deemed dividend on warrants 0        
Ending balance at Jun. 30, 2021 (112,930) $ 573 629,862 (742,776) (589)
Ending balance (in shares) at Jun. 30, 2021   57,280,000      
Beginning balance at Mar. 31, 2022 $ (126,683) $ 605 645,038 (770,903) (1,423)
Beginning balance (in shares) at Mar. 31, 2022 60,433,000 60,433,000      
Increase (Decrease) in Stockholders' Equity          
Net loss $ (10,220)     (10,220)  
Foreign currency translation adjustments, net (1,276)       (1,276)
Shares issued under employee stock purchase plan 0 $ 2 (2)    
Shares issued under employee stock purchase plan (in shares)   173,000      
Shares issued in connection with rights offering, net 66,323 $ 300 66,023    
Shares issued in connection with rights offering (in shares)   30,000,000      
Stock-based compensation 3,069   3,069    
Settlement of warrant down round provision 389   389    
Deemed dividend on warrants (389)   (389)    
Ending balance at Jun. 30, 2022 $ (68,787) $ 907 $ 714,128 $ (781,123) $ (2,699)
Ending balance (in shares) at Jun. 30, 2022 90,606,000 90,606,000